AJP - Regu AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (December 31, 2008). doi:10.1152/ajpregu.90330.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/R715    most recent
90330.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hodnett, B. L.
Right arrow Articles by Hester, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hodnett, B. L.
Right arrow Articles by Hester, R. L.
Submitted on March 31, 2008
Revised on December 23, 2008
Accepted on December 23, 2008

Attenuated PGI2 Synthesis in Obese Zucker Rats

Benjamin L. Hodnett1, Jennifer A. Dearman1, Cory B. Carter, and Robert L. Hester1*

1 University of Mississippi Medical Center

* To whom correspondence should be addressed. E-mail: rhester{at}physiology.umsmed.edu.

In obesity, skeletal muscle blood flow during exercise (functional hyperemia) is impaired. We have indirectly demonstrated that an altered arachidonic acid metabolism is responsible for the impaired functional vasodilation in the obese Zucker rat (OZR), a model of obesity. In this study we tested the hypothesis that there is an impaired release of PGI2, due to a nitration of PGI2 synthase (PGIS), which is associated with a decreased prostanoid receptor expression. PGI2, PGE2, and TXA2 release were determined in vitro using ELISA under basal conditions and in response to AA administration (50 µM). PGI2 and TXA2 receptor (IP and TP, respectively) immunofluorescence were determined in dispersed vascular smooth muscle cells (VSMCs). Nitration of tyrosine residues of the PGI2 synthase enzyme was determined using immunoprecipitation and western blot analysis. Following AA administration, PGI2 and PGE2 release were attenuated in OZR as compared to lean controls (LZR). Basal and AA-induced TXA2 release were not significantly different between groups. IP and TP immunofluorescence were not significantly different between OZR and LZR groups. OZR exhibited elevated nitration of tyrosine residues of PGIS as compared to LZR. These results suggest that alterations in the PGI2 pathway (attenuated PGI2 synthesis), and not the TXA2 pathway (normal TXA2 synthesis/no change in TP receptor expression), underlie the attenuated functional hyperemia in the OZR.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.